Entity Common Stock, Shares Outstanding of Vistagen Therapeutics, Inc. from 30 Jun 2011 to 11 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vistagen Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2011 to 11 Feb 2026.
  • Vistagen Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Feb 2026 was 39,620,317, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 39,620,317 +10,758,232 +37% 11 Feb 2026 10-Q 12 Feb 2026 2026 Q3
Q3 2025 39,495,451 +11,651,985 +42% 12 Nov 2025 10-Q 13 Nov 2025 2026 Q2
Q2 2025 29,157,733 +2,132,524 +7.9% 10 Jun 2025 10-K 17 Jun 2025 2025 FY
Q4 2024 28,862,085 +1,836,876 +6.8% 11 Feb 2025 10-Q 13 Feb 2025 2025 Q3
Q3 2024 27,843,466 +820,428 +3% 06 Nov 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 27,025,209 +19,152,730 +243% 07 Jun 2024 10-K 11 Jun 2024 2024 FY
Q4 2023 27,025,209 -192,301,317 -88% 12 Feb 2024 10-Q 13 Feb 2024 2024 Q3
Q3 2023 27,023,038 -179,813,307 -87% 09 Nov 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 7,872,479 -198,768,476 -96% 22 Jun 2023 10-K 28 Jun 2023 2023 FY
Q4 2022 219,326,526 +12,798,571 +6.2% 07 Feb 2023 10-Q 07 Feb 2023 2022 Q3
Q3 2022 206,836,345 +7,134,012 +3.6% 09 Nov 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 206,640,955 +15,258,605 +8% 22 Jun 2022 10-K 23 Jun 2022 2022 FY
Q4 2021 206,527,955 +64,833,542 +46% 09 Feb 2022 10-Q 10 Feb 2022 2022 Q3
Q3 2021 199,702,333 +125,704,276 +170% 09 Nov 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 191,382,350 +135,608,668 +243% 28 Jun 2021 10-K 29 Jun 2021 2021 FY
Q4 2020 141,694,413 +93,731,371 +195% 11 Feb 2021 10-Q 11 Feb 2021 2021 Q3
Q3 2020 73,998,057 +30,775,092 +71% 12 Nov 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 55,773,682 +13,150,717 +31% 26 Jun 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 47,963,042 +16,842,577 +54% 11 Feb 2020 10-Q 13 Feb 2020 2020 Q3
Q3 2019 43,222,965 +12,165,750 +39% 06 Nov 2019 10-Q 07 Nov 2019 2020 Q2
Q2 2019 42,622,965 +19,585,350 +85% 21 Jun 2019 10-K 25 Jun 2019 2019 FY
Q4 2018 31,120,465 +8,217,850 +36% 11 Feb 2019 10-Q 12 Feb 2019 2019 Q3
Q3 2018 31,057,215 +19,358,241 +165% 26 Oct 2018 10-Q 29 Oct 2018 2019 Q2
Q2 2018 23,037,615 +13,736,143 +148% 25 Jun 2018 10-K 26 Jun 2018 2018 FY
Q4 2017 22,902,615 +14,321,144 +167% 09 Feb 2018 10-Q 12 Feb 2018 2018 Q3
Q3 2017 11,698,974 +3,319,053 +40% 09 Nov 2017 10-Q 09 Nov 2017 2018 Q2
Q2 2017 9,301,472 +1,330,767 +17% 27 Jun 2017 10-K 29 Jun 2017 2017 FY
Q4 2016 8,581,471 +6,309,065 +278% 10 Feb 2017 10-Q 13 Feb 2017 2016 Q3
Q3 2016 8,379,921 +6,631,522 +379% 11 Nov 2016 10-Q 14 Nov 2016 2016 Q2
Q2 2016 7,970,705 +6,376,244 +400% 22 Jun 2016 10-K 24 Jun 2016 2016 FY
Q4 2015 2,272,406 +798,878 +54% 12 Feb 2016 10-Q 16 Feb 2016 2016 Q3
Q3 2015 1,748,399 13 Nov 2015 10-Q 16 Nov 2015 2016 Q2
Q2 2015 1,594,461 -23,857,416 -94% 25 Jun 2015 10-K 29 Jun 2015 2015 FY
Q4 2014 1,473,528 -21,888,349 -94% 13 Feb 2015 10-Q 17 Feb 2015 2015 Q3
Q2 2014 25,451,877 +4,185,910 +20% 19 Jun 2014 10-K 25 Jun 2014 2014 FY
Q4 2013 23,361,877 +3,270,090 +16% 10 Feb 2014 10-Q 14 Feb 2014 2013 Q3
Q3 2013 22,181,877 +4,838,627 +28% 12 Nov 2013 10-Q 14 Nov 2013 2013 Q2
Q2 2013 21,265,967 +3,706,004 +21% 12 Jul 2013 10-K 18 Jul 2013 2012 FY
Q4 2012 20,091,787 +3,585,276 +22% 12 Feb 2013 10-Q 14 Feb 2013 2012 Q3
Q3 2012 17,343,250 +2,101,346 +14% 12 Nov 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 17,559,963 +2,318,059 +15% 28 Jun 2012 10-K 02 Jul 2012 2011 FY
Q4 2011 16,506,511 13 Feb 2012 10-Q 14 Feb 2012 2011 Q3
Q3 2011 15,241,904 30 Sep 2011 10-Q 14 Nov 2011 2011 Q2
Q2 2011 15,241,904 30 Jun 2011 10-Q 22 Aug 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.